Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,176,000
New position
Shares Held
200,000
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#212
of 1,016 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Parkman Healthcare Partners LLC holds $82,007,868 across 7 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
202,907 | $16,796,641 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,624,279 | $16,242,790 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
364,269 | $14,945,957 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,807,621 | $14,316,358 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
541,190 | $9,367,998 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
398,782 | $7,162,124 | |
| 7 | VTRS |
Viatris Inc
This page
|
200,000 | $3,176,000 |
All Filings in VTRS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,176,000 | 200,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||